More than 330,000 doses of the Mosquirix malaria vaccine have been delivered to Cameroon as part of efforts to ramp up immunisation across Africa. Cameroon is the first African country to receive the vaccine after pilot programmes in Ghana, Kenya and Malawi.
A batch of 331,200 doses of the vaccine – which is also known as RTS,S and is manufactured by British drugmaker GSK – was offloaded in the capital Yaounde this week.
